|
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study |
|
|
|
Titel: |
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study |
Auteur: |
Rini, Brian I Pal, Sumanta K Escudier, Bernard J Atkins, Michael B Hutson, Thomas E Porta, Camillo Verzoni, Elena Needle, Michael N McDermott, David F |
Verschenen in: |
Lancet oncology |
Paginering: |
Jaargang 21 () nr. 1 pagina's 95-104 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|